ACTIVE SUBSTANCE / INN

RILPIVIRINE HYDROCHLORIDE

Brand name(s): COMPLERA, EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE, RILPIVIRINE HYDROCHLORIDE, EDURANT, EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE, ODEFSEY, EDURANT PED, JULUCA
FDA LISTED
PRESCRIPTION
NDA210192
NDA202022
ACTIVE SUBSTANCE
Rilpivirine Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
JANSSEN PRODS, LAURUS, GILEAD SCIENCES INC
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RILPIVIRINE HYDROCHLORIDEANDA218798SOMERSET THERAPS LLCPrescription
ODEFSEYNDA208351GILEAD SCIENCES INCPrescription
JULUCANDA210192VIIV HLTHCAREPrescription
COMPLERANDA202123GILEAD SCIENCES INCPrescription
EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATEANDA220232LAURUSPrescription
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDEANDA214095APOTEXPrescription
EDURANTNDA202022JANSSEN PRODSPrescription
EDURANT PEDNDA219016JANSSEN PRODSPrescription

FULL INTELLIGENCE ON RILPIVIRINE HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →